Clean Yield Group held its position in Colgate-Palmolive Co. (NYSE:CL) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,388 shares of the company’s stock at the end of the second quarter. Clean Yield Group’s holdings in Colgate-Palmolive were worth $541,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of the stock. State Street Corp increased its stake in Colgate-Palmolive by 1.2% in the first quarter. State Street Corp now owns 62,333,093 shares of the company’s stock worth $4,403,835,000 after buying an additional 742,556 shares during the last quarter. Wellington Management Group LLP increased its stake in Colgate-Palmolive by 22.2% in the first quarter. Wellington Management Group LLP now owns 41,060,286 shares of the company’s stock worth $2,900,908,000 after buying an additional 7,453,260 shares during the last quarter. BlackRock Fund Advisors increased its stake in Colgate-Palmolive by 3.5% in the first quarter. BlackRock Fund Advisors now owns 12,314,096 shares of the company’s stock worth $869,991,000 after buying an additional 413,740 shares during the last quarter. Geode Capital Management LLC increased its stake in Colgate-Palmolive by 1.4% in the first quarter. Geode Capital Management LLC now owns 7,235,633 shares of the company’s stock worth $510,171,000 after buying an additional 100,609 shares during the last quarter. Finally, BlackRock Group LTD increased its stake in Colgate-Palmolive by 1.2% in the first quarter. BlackRock Group LTD now owns 6,963,653 shares of the company’s stock worth $491,981,000 after buying an additional 81,398 shares during the last quarter. 72.97% of the stock is owned by institutional investors and hedge funds.
Shares of Colgate-Palmolive Co. (NYSE:CL) traded down 1.11% during mid-day trading on Tuesday, hitting $72.80. 3,267,330 shares of the company’s stock were exchanged. The company has a market capitalization of $64.90 billion, a price-to-earnings ratio of 46.88 and a beta of 0.63. Colgate-Palmolive Co. has a 52 week low of $61.40 and a 52 week high of $75.38. The firm has a 50 day moving average price of $73.58 and a 200-day moving average price of $72.44.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.01. The business had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a net margin of 9.04% and a return on equity of 1,980.28%. Colgate-Palmolive’s quarterly revenue was down 5.4% on a year-over-year basis. During the same quarter last year, the company posted $0.70 earnings per share. On average, equities analysts anticipate that Colgate-Palmolive Co. will post $2.80 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th will be paid a $0.39 dividend. The ex-dividend date of this dividend is Thursday, October 20th. This represents a $1.56 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s payout ratio is 100.65%.
CL has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a report on Monday. Exane BNP Paribas downgraded shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating in a report on Friday, July 29th. Goldman Sachs Group Inc. restated a “neutral” rating and issued a $76.00 target price (up from $74.00) on shares of Colgate-Palmolive in a report on Friday, July 15th. JPMorgan Chase & Co. reiterated a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a research note on Friday, July 29th. Finally, B. Riley reiterated a “neutral” rating and set a $71.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, August 3rd. Fourteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $74.68.
In other news, Director Ellen M. Hancock sold 4,584 shares of the firm’s stock in a transaction on Tuesday, August 2nd. The shares were sold at an average price of $74.82, for a total value of $342,974.88. Following the sale, the director now owns 203,632 shares in the company, valued at $15,235,746.24. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CTO Patricia Verduin sold 3,666 shares of the firm’s stock in a transaction on Friday, July 15th. The stock was sold at an average price of $74.98, for a total transaction of $274,876.68. Following the completion of the sale, the chief technology officer now owns 54,602 shares in the company, valued at approximately $4,094,057.96. The disclosure for this sale can be found here. 1.05% of the stock is currently owned by insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Co. (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related companies with MarketBeat.com's FREE daily email newsletter.